Telaprevir - CAS# 402957-28-2 Catalog No.:M10865-2 1843(11):2481-2491

1843(11):2481-2491

InChiKey: XXZGNAZRWCBSBK-WFVOFKTRSA-N

Momin RA et al

Tucidinostat selectively binds to and inhibits HDAC leading to an increase of acetylation levels of histone protein H3

Chemical Name: 2-(pyridin-4-yl)-1H

Telaprevir - CAS# 402957-28-2 Catalog No.:M10865-2 1843(11):2481-2491Telaprevir (VX 950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3. 4A serine protease. Telaprevir is only indicated for use against hepatitis C genotype 1 viral infections and has not